11. P781 Treatment outcome of tofacitinib dose reduction to 5 mg BID vs remaining on 10 mg BID in patients with Ulcerative Colitis who were in stable remission on 10 mg BID: Updated 30-month data from the double-blind, randomised RIVETING study. (30th January 2023) Authors: Rubin, D T; Panés, J; Torres, J; Kobayashi, T; Su, C; Lawendy, N; Modesto, I; Segovia, M; Gardiner, S; Wang, W; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. What's the use of Archimedes?. Issue 2 (1st August 2002) Authors: Rudolf, M; Rowland, G; Das, G; Gardiner, S; Khan, F; Krishnan, V; Mylona, F; Preece, J; Omosigho, C; Willey, C; Williamson, A Journal: Archives of disease in childhood Issue: Volume 87:Issue 2(2002) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗